Page 30 - Network Magazine Summer 2019
P. 30

                 LifeAire Brings Air Purity to
Critical-Care Medical Environments
Medical facilities strive to keep surfaces in critical care environments as sterile as possible. But one of the most serious threats in those areas is in the air surrounding the patients and staff. Airborne chemical and biological pathogens can readily bypass many air filtration mea- sures commonly used by medical facilities, including
Dr. Worrilow’s research determined that external environmental events can greatly impact the clinical outcomes of a facility. The VOCs that permeate basic filtration are generated through many sources, including seasonal changes, construction, vehicle exhaust, paint, cleaning fluids, and road resurfacing. Dr. Worrilow found
that the IVF success rate dropped precipitously when nearby projects, such as road resurfacing, contaminated the air. She also determined that airborne contaminants play a major role, not only in reproduc- tive and cell culture success, but also in the rate of hospital acquired infections (HAI) within hospital and assisted living settings.
This discovery was the genesis of the technology of Allentown- based LifeAire Systems. Dr. Worrilow led a team of chemists, engineers, and physicists to
develop the LifeAire System — a patented, in-duct
air purification system that incorporates a multi-stage approach with a blend of strategies that capture, kill, and filter airborne chemical and biological contaminants. Un- like common HEPA filters, the LifeAire System provides comprehensive molecular destruction of biological and chemical contaminants, delivering air with purity levels as high as 99.99 percent in a single pass.
With financial investments and strategic business insights from the Ben Franklin Technology Partners of Northeast- ern Pennsylvania, Dr. Worrilow was able to move forward with transforming her realization into a commercially viable product that benefits several types of medical and research facilities. Teaming with H.T. Lyons, also based
 HEPA, ULPA, and UV light, and can enter areas where compromised patients, human embryos, and gene/cell therapies are susceptible to attack and contamination.
With a focus on this, LifeAire Systems’ Founder and CEO, Dr. Kathryn C. Worrilow, conducted more than two decades of research into air remediation, initially in the In Vitro Fertilization (IVF) environment. She found that the first-line air filtration techniques in use, even combined with best-practice protocols, were inadequate to guard against airborne volatile organic compounds (VOC). This shortcoming places operating rooms, recovery rooms, rehabilitation centers, long-term care facilities, and cell manufacturing facilities at risk.

   28   29   30   31   32